These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23478255)

  • 1. Lipids: Targeting cascade screening in familial hypercholesterolaemia.
    Wilson C
    Nat Rev Cardiol; 2013 May; 10(5):238. PubMed ID: 23478255
    [No Abstract]   [Full Text] [Related]  

  • 2. Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies.
    Martin AC; Bell DA; Brett T; Watts GF
    Curr Opin Lipidol; 2017 Aug; 28(4):321-327. PubMed ID: 28426524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemia.
    Datta BN; McDowell IF; Rees A
    Curr Opin Lipidol; 2010 Aug; 21(4):366-71. PubMed ID: 20613514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hinterland of familial hypercholesterolaemia: what do we not know?
    Wierzbicki AS; Watts GF
    Curr Opin Lipidol; 2015 Dec; 26(6):475-83. PubMed ID: 26780001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of cascade testing for the detection of familial hypercholesterolaemia.
    Hadfield SG; Humphries SE
    Curr Opin Lipidol; 2005 Aug; 16(4):428-33. PubMed ID: 15990592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetics and screening of familial hypercholesterolaemia.
    Henderson R; O'Kane M; McGilligan V; Watterson S
    J Biomed Sci; 2016 Apr; 23():39. PubMed ID: 27084339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Hypercholesterolaemia Diagnosis and Management.
    Alonso R; Perez de Isla L; Muñiz-Grijalvo O; Diaz-Diaz JL; Mata P
    Eur Cardiol; 2018 Aug; 13(1):14-20. PubMed ID: 30310464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors.
    Pećin I; Hartgers ML; Hovingh GK; Dent R; Reiner Ž
    Eur J Prev Cardiol; 2017 Sep; 24(13):1383-1401. PubMed ID: 28644091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy).
    Descamps OS; Van Caenegem O; Hermans MP; Balligand JL; Beauloye C; Bondue A; Carlier S; Castermans E; Chenot F; Claeys M; De Block C; de Leener A; De Meester A; Demeure F; De Raedt H; Desmet W; Elegeert I; Guillaume M; Hoffer E; Kacenelenbogen R; Lancellotti P; Langlois M; Leone A; Mertens A; Paquot N; Vanakker O; Vanoverschelde JL; Verhaegen A; Vermeersch P; Wallemacq C; Rietzschel E;
    Atherosclerosis; 2018 Oct; 277():369-376. PubMed ID: 30270073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting cascade screening in familial hypercholesterolaemia.
    Wilson C
    Nat Rev Endocrinol; 2013 May; 9(5):254. PubMed ID: 23478325
    [No Abstract]   [Full Text] [Related]  

  • 11. Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies.
    Wald DS; Bestwick JP
    Atherosclerosis; 2020 Jan; 293():57-61. PubMed ID: 31837509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial hypercholesterolaemia and primary hypothyroidism: coexistence of both disorders in a young woman with severe hypercholesterolaemia.
    Illingworth DR; McClung MR; Connor WE; Alaupovic P
    Clin Endocrinol (Oxf); 1981 Feb; 14(2):145-52. PubMed ID: 7261412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes.
    Marks D; Thorogood M; Neil SM; Humphries SE; Neil HA
    J Med Screen; 2006; 13(3):156-9. PubMed ID: 17007658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
    Truong TH; Kim NT; Nguyen MNT; Pang J; Hooper AJ; Watts GF; Do DL
    Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial hypercholesterolaemia and quality of life in family members.
    Hollman G; Olsson AG; Ek AC
    Prev Med; 2003 May; 36(5):569-74. PubMed ID: 12689802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnosis of familial hypercholesterolaemia.
    Graham CA; Latten MJ; Hart PJ
    Curr Opin Lipidol; 2017 Aug; 28(4):313-320. PubMed ID: 28463860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening of school children for familial hypercholesterolemia].
    Jepsen BS; Micic S; Hansen B; Larsen SO; Pedersen BN; Skovby F
    Ugeskr Laeger; 1994 Mar; 156(13):1962-4. PubMed ID: 8009690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E polymorphism is not associated with lipid levels and coronary artery disease in Greek patients with familial hypercholesterolaemia.
    Pitsavos C; Choumerianou DM; Skoumas J; Maumus S; Stefanadis C; Dedoussis GV; Visvikis-Siest S
    Clin Exp Med; 2005 Dec; 5(4):196-201. PubMed ID: 16362800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of familial hypercholesterolaemia: external validation of the FAMCAT clinical case-finding algorithm to identify patients in primary care.
    Weng S; Kai J; Akyea R; Qureshi N
    Lancet Public Health; 2019 May; 4(5):e256-e264. PubMed ID: 31054643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
    Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF
    Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.